- English
- Français Canadien
- 日本語
Syneos Health: A Veeva-Preferred Partner With Deep Expertise to Help You Assess, Build and Operate Veeva CDMS
The increasingly complex and fast-moving clinical trial landscape has underscored a need for an agile and innovative Clinical Data Management System (CDMS).
Veeva’s Vault CDMS is a modern cloud application for clinical data management that combines EDC, coding, data cleaning and reporting on a single cloud platform.Top 20 pharmaceutical companies, emerging biopharma companies and leading CROs are moving toward Vault CDMS to build study databases faster, improve efficiency for study teams and drive greater consistency in data management.
Syneos Health has demonstrable evidence that Veeva CDMS, when implemented and delivered correctly, can reduce end-to-end data management (DM) cycle times by up to 75%.
As a Veeva preferred services partner, Syneos Health can help you implement and transition to Veeva Vault efficiently, ensuring “business as usual” phase is reached swiftly—laying the foundation for delivery excellence. Schedule a time for a discussion with one of our experts about how we can support your needs.
Delivering Expert Solutions Across the Spectrum of CDMS Implementation
If you are considering taking part or all of the Veeva stack on-board, you want to know that making a Veeva investment will secure you reduced costs, reduction in cycle time and high quality. Syneos Health has the most experience—across all CROs—implementing and delivering the Veeva stack. We can give a full objective view of the benefits of Veeva and have a firewalled consulting business that can provide impartial advice.
For those who have committed to some or all of the Veeva stack, swift implementation and process redefinition is critically important. Our "out of the box" solution for implementation of the stack in conjunction with Veeva—which we have already implemented for several pharma customers—can have you realizing the benefits sooner.
If you have already implemented the stack, or you have worked with Veeva for implementation and want to realize cost savings and timeline reductions when it comes to DM delivery—you’ve come to the right place. We offer demonstrable models to deliver DM Functional Service Provider (FSP) services on client Veeva Vault, and through our unique and dynamic FSP/FSX approach, we can customize solutions to successfully meet your individual needs.
Ask about our “Gold Standard” case study that demonstrates reduction in cycle times, cost and maintenance of high quality. We are also the primary "build" CRO partner for Veeva and have more builders than Veeva themselves—no other CRO has this extensive build capability. And if you are looking for “constant database” (CDB) functionality, we are also experienced with this next-generation DM platform and can provide top-notch support.
Meet Our Experts
|
Rachel Belani-Barker Managing Director R&D Advisory |
Nicholas Lakin Sr Managing Director R&D Advisory |
|
Claire Riches Senior Vice President Global Client Solutions |
Mike McDevitt Senior Vice President バイオメトリクス |
WHY SYNEOS HEALTH?
We have done this before
Our teams have done similar assessments and defined processes for other clients, including Top 10 pharma
We have an experienced team
Our teams have a blend of consulting skills and subject matter expertise to deliver projects with best outputs for our clients. This includes a pool of clinical and independent SMEs to provide expertise. We have also developed robust frameworks and tools to accelerate process design and analysis
We are a preferred Veeva services partner
We understand Veeva’s suite well, have in house certified Vault consultants who have helped several clients implement and transition to Veeva Vault
詳細に興味がおありですか？ Explore Insights Hub for the latest industry perspectives or click on the resources below:
Syneos Health Global Regulatory Affairs Solutions
ON-DEMAND WEBINAR: EU CTRへの対応はお済みですか？
Future-Proofing Clinical Trial Performance: Dynamic Service Provision Combines the Best of FSP and FSO Options
Ensuring Data Quality During a Pandemic
Mapping the Future of Decentralized Clinical Trials
Emerging Biopharmaceutical Companies: Enabling Talent to Innovate in an Evolving Organization
When
Wed, Oct 19, 01:00 pm to 03:00 pm
